Subchondral treatment of joint pain of the spine

US9962267B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9962267-B2
Application numberUS-201715691133-A
CountryUS
Kind codeB2
Filing dateAug 30, 2017
Priority dateAug 7, 2011
Publication dateMay 8, 2018
Grant dateMay 8, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for altering the natural history of degenerative disc disease and osteoarthritis of the spine are proposed. The methods focus on the prevention, or delayed onset or progression of, subchondral defects such as bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis or degenerative disc disease in the spine and thereby treat pain.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of injecting an injectable fluid material into a targeted treatment area in a subchondral region of a facet in a spinal segment of a patient for inhibiting progression of bone marrow edema identified in the subchondral region, the method comprising: identifying bone marrow edema in a facet in a spinal segment of a patient, the bone marrow edema occurring in a subchondral region of the facet, the subchondral region of the facet occurring under an articular surface of the facet; creating, in the facet that contains the bone marrow lesion in the subchondral region, a subchondral injection path to a targeted treatment area for injecting an injectable fluid material into the targeted treatment area, wherein the targeted treatment area includes an area in the subchondral region where the bone marrow edema was identified, and wherein said creating preserves an existing condition of the articular surface of the facet; and injecting an injectable fluid material into the targeted treatment area via the subchondral injection path so that at least some of the injectable fluid material is introduced into defective bone that remains in the identified bone marrow edema following said creating for becoming less fluid in the defective bone for reinforcing the defective bone, wherein the injectable fluid material includes an osteogenic, osteoconductive and/or osteoinductive material. 2. The method of claim 1 , wherein said identifying includes identifying with MRI. 3. The method of claim 1 , wherein the injectable fluid material is left in the targeted treatment area without also delivering and leaving a solid structural implant in the targeted treatment area in addition to the injectable fluid material. 4. The method of claim 1 , wherein said creating is conducted without further creating a void inside the facet in or adjacent to the targeted treatment area. 5. The method of claim 1 , wherein the injectable fluid material includes bone marrow. 6. The method of claim 1 , wherein the injectable fluid material includes a calcium phosphate. 7. The method of claim 1 , wherein said creating is performed percutaneously. 8. The method of claim 1 , wherein the subchondral injection path is created with a needle. 9. A method of injecting an injectable fluid material into a targeted treatment area in a subchondral region of a facet in a spinal segment of a patient for inhibiting progression of bone marrow edema identified in the subchondral region, the method comprising: identifying bone marrow edema in a facet in a spinal segment of a patient so as to establish an identified bone marrow edema, the identified bone marrow edema occurring in a subchondral region of the facet, the subchondral region of the facet occurring under an articular surface of the facet; targeting a treatment area in the subchondral region of the facet so as to establish a targeted treatment area for receiving treatment, wherein the targeted treatment area includes an area in the identified bone marrow edema; creating, in the facet that contains the bone marrow lesion in the subchondral region, a subchondral injection path to the targeted treatment area for injecting an injectable fluid material into the targeted treatment area, wherein said creating preserves an existing condition of the articular surface of the facet; and injecting an injectable fluid material into the targeted treatment area via the subchondral injection path so that at least some of the injectable fluid material is introduced into defective bone that remains in the identified bone marrow edema following said creating for becoming less fluid in the defective bone for reinforcing the defective bone, wherein the injectable fluid material is left in the targeted treatment area without also delivering and leaving a solid structural implant in the targeted treatment area in addition to the injectable fluid material, and wherein the injectable fluid material includes an osteogenic, osteoconductive and/or osteoinductive material. 10. The method of claim 9 , wherein said identifying includes identifying with MRI. 11. The method of claim 9 , wherein said creating is conducted without further creating a void inside the facet in or adjacent to the targeted treatment area. 12. The method of claim 9 , wherein the targeted treatment area is in the identified bone marrow edema in the subchondral region of the facet. 13. The method of claim 9 , wherein the targeted treatment area is in and adjacent to the identified bone marrow edema in the subchondral region of the facet. 14. The method of claim 9 , wherein the injectable fluid material includes bone marrow. 15. The method of claim 9 , wherein the injectable fluid material includes a calcium phosphate. 16. The method of claim 9 , wherein said creating is performed percutaneously. 17. The method of claim 9 , wherein the subchondral injection path is created with a needle.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9962267B2 cover?
Methods for altering the natural history of degenerative disc disease and osteoarthritis of the spine are proposed. The methods focus on the prevention, or delayed onset or progression of, subchondral defects such as bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis or degenerative disc disease in the spine and thereby treat pain.
Who is the assignee on this patent?
Zimmer Knee Creations Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/4405. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).